The A5 nanobody is around 10 times smaller than conventional antibodies, helping it to penetrate deep into tissues. Crucially, it can bind selectively to cancer cells, leading to a reduction of more ...

Results from the Phase II OptiTROP-Lung01 trial (NCT05351788) showed that Sichuan Kelun-Biotech’s sac-TMT combined with ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan ...

Officials said these will significantly enhance outreach to rural and underserved communities that face some of the highest ...

Rates of the world's deadliest cancer appear to be low in sub-Saharan Africa. But that statistic is masking the scope of the ...

She's one of a growing number of non-smokers doctors are seeing with lung cancer. Although smoking remains the leading risk ...

A research team has developed a nanobody-based technology that can precisely identify and attack only lung cancer cells, ...

Dean Comstock was 27 when he received the frightening diagnosis of terminal lung cancer. The singer and runner had never ...

A research team led by Dr. Juyeon Jung at the Bio-Nano Research Center, Korea Research Institute of Bioscience and ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

Five-year survival rates for people with lung cancer have doubled since the 1990s, but the disease still kills more patients ...